Lord, Abbett & Co. LLC Rx Sight, Inc. Transaction History
Lord, Abbett & Co. LLC
- $30.4 Billion
- Q1 2024
A detailed history of Lord, Abbett & Co. LLC transactions in Rx Sight, Inc. stock. As of the latest transaction made, Lord, Abbett & Co. LLC holds 1,772,390 shares of RXST stock, worth $104 Million. This represents 0.3% of its overall portfolio holdings.
Number of Shares
1,772,390
Previous 1,977,000
10.35%
Holding current value
$104 Million
Previous $79.7 Million
14.69%
% of portfolio
0.3%
Previous 0.29%
Shares
5 transactions
Others Institutions Holding RXST
# of Institutions
199Shares Held
25.6MCall Options Held
67KPut Options Held
2K-
Black Rock Inc. New York, NY2.11MShares$123 Million0.0% of portfolio
-
Artisan Partners Limited Partnership Milwaukee, WI1.9MShares$111 Million0.15% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.52MShares$89.1 Million0.0% of portfolio
-
Morgan Stanley New York, NY1.13MShares$65.8 Million0.0% of portfolio
-
Summit Partners Public Asset Management, LLC Boston, MA783KShares$45.8 Million1.43% of portfolio
About RxSight, Inc.
- Ticker RXST
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 27,638,900
- Market Cap $1.62B
- Description
- RxSight, Inc., a medical technology company, engages in the research and development, manufacture, and sale of light adjustable intraocular lenses (LAL) used in cataract surgery in the United States and internationally. It offers RxSight system that enables doctors to customize and enhance the visual acuity for patients after cataract surgery. T...